The Scientist

» iPSCs, immunology and disease/medicine

Most Recent

image: Contributors

Contributors

By and | May 1, 2016

Meet some of the people featured in the May 2016 issue of The Scientist.

0 Comments

image: Skin Cells Turned Into Immature Sperm

Skin Cells Turned Into Immature Sperm

By | April 29, 2016

Meet some of the people featured in the May 2016 issue of The Scientist.

0 Comments

image: Antibodies Prevent HIV Infection in Monkeys

Antibodies Prevent HIV Infection in Monkeys

By | April 29, 2016

Meet some of the people featured in the May 2016 issue of The Scientist.

0 Comments

image: Study: “Dirty” Mice More Humanlike

Study: “Dirty” Mice More Humanlike

By | April 21, 2016

Meet some of the people featured in the May 2016 issue of The Scientist.

2 Comments

image: “Hunger Hormone” No More?

“Hunger Hormone” No More?

By | April 20, 2016

Meet some of the people featured in the May 2016 issue of The Scientist.

3 Comments

image: Theranos in Criminal Probe

Theranos in Criminal Probe

By | April 19, 2016

Meet some of the people featured in the May 2016 issue of The Scientist.

2 Comments

image: AACR Q&A: Elaine Mardis

AACR Q&A: Elaine Mardis

By | April 18, 2016

Meet some of the people featured in the May 2016 issue of The Scientist.

0 Comments

image: Monitoring Mitochondrial Mutations

Monitoring Mitochondrial Mutations

By | April 18, 2016

Meet some of the people featured in the May 2016 issue of The Scientist.

0 Comments

image: Tracking Zika’s Evolution

Tracking Zika’s Evolution

By | April 15, 2016

Meet some of the people featured in the May 2016 issue of The Scientist.

1 Comment

image: Psychedelic Neuroimaging

Psychedelic Neuroimaging

By | April 13, 2016

Meet some of the people featured in the May 2016 issue of The Scientist.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech